HCV viral load at baseline and at week 4 of telaprevir/boceprevir based triple therapies are associated with virological outcome in HIV/hepatitis C co-infected patients
Keywords: HIV/HCV-coinfection; HCV undetectable viral load; HCV sustained virologic response; SVR; Telaprevir; Boceprevir; HCV protease inhibitors; Low HCV viral load;